Hossain, Delowar
Scott, Stephen H.
Cluff, Tyler
Dukelow, Sean P.
Funding for this research was provided by:
an Ontario Research Foundation – Research Excellence grant (ORE-RE 04-47)
CIHR in Stroke Rehabilitation Research (MOP 106662)
A Heart and Stroke Foundation of Canada Grant-in-Aid (G-13-0003029)
Article History
Received: 1 April 2022
Accepted: 18 January 2023
First Online: 27 January 2023
Declarations
:
: SHS is the co-founder and Chief Scientific Officer of Kinarm (formally known as BKIN Technologies), the company that commercializes the Kinarm robotic device used in this study. All other authors confirm no conflict of interest.
: The protocol was approved by the University of Calgary Conjoint Health Research Ethics Board and the Queen’s University Research Ethics Board. All participants gave written informed consent before performing the assessment.
: Consent to publish was obtained from all participants; and also, consent was obtained for Fig. A.
: SHS is the co-founder and Chief Scientific Officer of Kinarm (formally known as BKIN Technologies), the company that commercializes the Kinarm robotic device used in this study. All other authors confirm no conflict of interest.